Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
Journal of Environmental Pathology, Toxicology and Oncology
Fator do impacto: 1.241 FI de cinco anos: 1.349 SJR: 0.356 SNIP: 0.613 CiteScore™: 1.61

ISSN Imprimir: 0731-8898
ISSN On-line: 2162-6537

Journal of Environmental Pathology, Toxicology and Oncology

DOI: 10.1615/JEnvironPatholToxicolOncol.v21.i2.20
9 pages

Prostaglandins and the Regulation of Tumor Growth

David Bishop-Bailey
Department of Cardiac, Vascular and Inflammation Research, William Harvey Research Institute, Charterhouse Square, Queen Mary's University, London, UK EC1M 6BQ
Sara Calatayud
Department of Cardiac, Vascular and Inflammation Research, William Harvey Research Institute, Charterhouse Square, Queen Mary's University, London, UK EC1M 6BQ
Timothy D. Warner
Department of Cardiac, Vascular and Inflammation Research, William Harvey Research Institute, Charterhouse Square, Queen Mary's University, London, UK EC1M 6BQ
Timothy Hla
Center for Vascular Biology, UCONN Health Center; 263 Farmington Avenue, Farmington, CT 06030
Jane A. Mitchell
Unit of Critical Care Medicine, National Heart and Lung Institute, Imperial College School of Medicine, Dovehouse Street, London, UK SW3 6LY

RESUMO

Increased expression of inducible cyclooxygenase (COX-2) is associated with a wide variety of tumors. In addition, inhibitors of COX have shown a great deal of promise in vitro and in animal models as potential antitumor therapies. COX enzymes use the substrate arachidonic acid to produce prostaglandin (PG)H2, the precursor to all the prostanoids. Therefore, the release of individual prostanoids depends on the abundance and functional coupling to individual PG synthase isoenzymes. Colony stimulating factors (CSFs) are also potential antitumor agents via their ability to augment the immune response. When COX-2 is expressed, the CSF, granulocyte macrophage (GM)-CSF, and granulocyte (G)-CSF are exquisitely sensitive to endogenous PGs. In addition, the ability of COX-2 to suppress GM-CSF release is mediated via traditional IP/EP prostanoid receptors linked to cAMP-dependent pathways. Therefore, inhibition of COX-2 in tumors may have the important side effect of enhancing the immune response. Recently, novel signaling pathways for PG derivatives have been discovered; in particular the PGD2 dehydration product 15-deoxy-D12,14-(15d)-PGJ2 was identified as a ligand for the nuclear receptor/transcription factor, peroxisome proliferator-activated receptor (PPAR)-g. PPARg is present at high levels in a number of tumors, and is also present in endothelial cells. 15d-PGJ2 as well as other nonprostanoid PPARg ligands are antitumor, and antiangiogenic, by dramatically inhibiting the growth of tumor cells and endothelial cells by either causing terminal differentiation, and/or by inducing apoptosis. We have recently found that, in addition to IP and EP ligands generated by COX-2, PPARg ligands similarly inhibit GM-CSF release. Effecting individual prostanoid pathways at the level of COX expression, profile of PG products produced or selective PG receptor activation may produce novel therapies, either dependent or independent of CSF release, to target cancers.


Articles with similar content:

The Role of Nitric Oxide and Cyclooxygenase-2 in Attenuating Apoptosis
Journal of Environmental Pathology, Toxicology and Oncology, Vol.21, 2002, issue 2
Andreas von Knethen, Bernhard Brune
Features and Functions of gd T Lymphocytes: Focus on Chemokines and Their Receptors
Critical Reviews™ in Immunology, Vol.23, 2003, issue 5-6
Dieter Kabelitz, Daniela Wesch
Integrin Modulating Factor: A 30-kD Protein that Modulates the Expression and Function of a5b1 Integrin Receptor
Journal of Environmental Pathology, Toxicology and Oncology, Vol.20, 2001, issue 3
Utpal Sanyal, Subrata Ray, Nibedita Chattopadhyay, Amitava Chatterjee, Nupur Biswas
lnterleukin-10 in the Brain
Critical Reviews™ in Immunology, Vol.21, 2001, issue 5
Wen-Hong Shen, Suzanne R. Broussard, Rodney W. Johnson, Robert Dantzer, Klemen Strle, Gregory G. Freund, Keith W. Kelley, Jian-Hua Zhou
Role of the D Prostanoid Receptor 1 in the Modulation of Immune and Inflammatory Responses
Critical Reviews™ in Immunology, Vol.24, 2004, issue 5
Christelle Faveeuw, Philippe Gosset, Veronique Angeli, Francois Trottein